Signatur Biosciences transforms standard qPCR machines into precision diagnostic tools by condensing complex RNA signatures into single PCR assays. This platform enables decentralized, faster, and more affordable molecular diagnostics compatible with existing hospital infrastructure. The technology allows clinicians to deliver precision insights for complex diseases, such as cancer prognosis, using widely accessible PCR equipment.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional PCR diagnostics for complex diseases require either running numerous tests in parallel or upgrading to expensive, complicated machinery like sequencers. Complex preparation and analysis workflows, along with high-tech machines, increase the time and cost of diagnosis, creating a bottleneck for precision medicine adoption.
Solution
Signatur Biosciences develops smart PCR kits that utilize their PCRchitectur technology to detect gene expression signatures for complex diseases using standard qPCR machines. This approach eliminates the need for multiple tests and expensive equipment, streamlining the diagnostic process and making precision medicine more accessible. The kits seamlessly integrate into existing clinical workflows and ubiquitous laboratory instruments. The PCRchitectur technology condenses the detection and interpretation of a panel of RNA biomarkers into a single test.
Target Audience
The primary target audience includes clinical laboratories and healthcare providers seeking to improve the accessibility and efficiency of precision diagnostics for complex diseases.
Features
- Smart PCR kits designed to detect gene expression signatures.
- PCRchitectur technology enables the use of standard qPCR machines for complex disease diagnosis.
- Streamlined workflow integrates seamlessly into existing clinical laboratory processes.
- Eliminates the need for multiple PCR tests or expensive sequencing equipment.
- Condenses the detection and interpretation of multiple RNA biomarkers into a single test.